Norbit ASA
F:4NK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Norbit ASA
F:4NK
|
NO |
|
BRC Inc
NYSE:BRCC
|
US |
|
Coface SA
OTC:CFACY
|
FR |
|
C
|
Cidara Therapeutics Inc
F:20D
|
US |
|
C
|
CureVac NV
F:5CV
|
DE |
Wall St Price Targets
4NK Price Targets Summary
Norbit ASA
According to Wall Street analysts, the average 1-year price target for 4NK is 22.22 EUR with a low forecast of 20.54 EUR and a high forecast of 24.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4NK's stock price target?
Price Target
22.22
EUR
According to Wall Street analysts, the average 1-year price target for 4NK is 22.22 EUR with a low forecast of 20.54 EUR and a high forecast of 24.27 EUR.
What is the Revenue forecast for Norbit ASA?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Norbit ASA?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Operating Income has been 35%. The projected CAGR for the next 8 years is 11%.
What is the Net Income forecast for Norbit ASA?
Projected CAGR
22%
Over the last 6 years, the compound annual growth rate for Net Income has been 32%. The projected CAGR for the next 3 years is 22%.
